AVTRPA.PFD (Avantor) Gross-Profit-to-Asset % : 17.51% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Avantor Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Avantor's annualized Gross Profit for the quarter that ended in Mar. 2025 was $2,139.60 Mil. Avantor's average Total Assets over the quarter that ended in Mar. 2025 was $12,220.45 Mil. Therefore, Avantor's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 17.51%.

Avantor Gross-Profit-to-Asset % Historical Data

The historical data trend for Avantor's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avantor Gross-Profit-to-Asset % Chart

Avantor Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

21.14

21.03

19.03

17.88

18.17

Avantor Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															17.73	18.27	17.68	18.05	17.51

Competitive Comparison of Avantor's Gross-Profit-to-Asset %

For the Medical Instruments & Supplies subindustry, Avantor's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avantor's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avantor's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Avantor's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

Avantor Gross-Profit-to-Asset % Calculation

Avantor's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2024 )	/	( (Total Assets (A: Dec. 2023 )	+	Total Assets (A: Dec. 2024 ))	/ count )
	=	2279.3	/	( (12972.7	+	12114.5)	/ 2 )
	=	2279.3	/	12543.6
	=	18.17 %

Avantor's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
	=	2139.6	/	( (12114.5	+	12326.4)	/ 2 )
	=	2139.6	/	12220.45
	=	17.51 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Avantor Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Avantor's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avantor Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avantor Inc (NYSE:AVTRpA.PFD) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

AVTR:USA AVG:Germany AVTR:Austria

Address

100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, USA, 19087

Website

https://www.avantorsciences.com

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.